DK1039908T3 - Præparat med indhold af en molekylær dispersion med forøget biotilgængelighed - Google Patents

Præparat med indhold af en molekylær dispersion med forøget biotilgængelighed

Info

Publication number
DK1039908T3
DK1039908T3 DK98963031T DK98963031T DK1039908T3 DK 1039908 T3 DK1039908 T3 DK 1039908T3 DK 98963031 T DK98963031 T DK 98963031T DK 98963031 T DK98963031 T DK 98963031T DK 1039908 T3 DK1039908 T3 DK 1039908T3
Authority
DK
Denmark
Prior art keywords
preparation containing
increased bioavailability
molecular dispersion
dispersion
molecular
Prior art date
Application number
DK98963031T
Other languages
Danish (da)
English (en)
Inventor
Surendra A Sangekar
Ping I Lee
Amin A Nomeir
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1039908T3 publication Critical patent/DK1039908T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98963031T 1997-12-22 1998-12-17 Præparat med indhold af en molekylær dispersion med forøget biotilgængelighed DK1039908T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99716897A 1997-12-22 1997-12-22
PCT/US1998/026218 WO1999032118A1 (en) 1997-12-22 1998-12-17 Molecular dispersion composition with enhanced bioavailability

Publications (1)

Publication Number Publication Date
DK1039908T3 true DK1039908T3 (da) 2004-05-03

Family

ID=25543717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98963031T DK1039908T3 (da) 1997-12-22 1998-12-17 Præparat med indhold af en molekylær dispersion med forøget biotilgængelighed

Country Status (27)

Country Link
EP (1) EP1039908B1 (cs)
JP (2) JP2001526227A (cs)
KR (1) KR100597331B1 (cs)
CN (1) CN1116039C (cs)
AR (1) AR017436A1 (cs)
AT (1) ATE260105T1 (cs)
AU (1) AU761994C (cs)
BR (1) BR9813728A (cs)
CA (1) CA2315685C (cs)
CO (1) CO4970793A1 (cs)
CZ (1) CZ295956B6 (cs)
DE (1) DE69821984T2 (cs)
DK (1) DK1039908T3 (cs)
ES (1) ES2214757T3 (cs)
HU (1) HU229052B1 (cs)
ID (1) ID28304A (cs)
IL (1) IL136460A0 (cs)
MY (1) MY126580A (cs)
NO (1) NO327383B1 (cs)
NZ (1) NZ504834A (cs)
PE (1) PE20000012A1 (cs)
PL (1) PL192423B1 (cs)
PT (1) PT1039908E (cs)
SK (1) SK285662B6 (cs)
TW (1) TW527196B (cs)
WO (1) WO1999032118A1 (cs)
ZA (1) ZA9811592B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
KR20100049695A (ko) * 2002-03-04 2010-05-12 테바 파마슈티컬 인더스트리즈 리미티드 방출 조절 제형
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008136394A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の製造方法及びその製造中間体
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms
WO2016198983A1 (en) 2015-06-09 2016-12-15 Bend Research Inc. Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
SG43179A1 (en) * 1991-12-18 1997-10-17 Warner Lambert Co A process for the prepatation of a solid dispersion
JPH0848632A (ja) * 1994-08-08 1996-02-20 Kanebo Ltd エトポシドを含有する固形組成物および固形製剤
SK86198A3 (en) * 1995-12-22 1999-02-11 Schering Corp Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
DE69730241T2 (de) * 1996-06-28 2005-08-11 Schering Corp. Feste lösung eines fungizids mit erhöhter bioverfügbarkeit

Also Published As

Publication number Publication date
CN1116039C (zh) 2003-07-30
WO1999032118A1 (en) 1999-07-01
NO327383B1 (no) 2009-06-22
HU229052B1 (en) 2013-07-29
EP1039908A1 (en) 2000-10-04
DE69821984T2 (de) 2004-12-30
TW527196B (en) 2003-04-11
NZ504834A (en) 2001-12-21
PT1039908E (pt) 2004-06-30
JP2010059212A (ja) 2010-03-18
AR017436A1 (es) 2001-09-05
CO4970793A1 (es) 2000-11-07
CZ295956B6 (cs) 2005-12-14
SK8962000A3 (en) 2001-07-10
ID28304A (id) 2001-05-10
EP1039908B1 (en) 2004-02-25
ES2214757T3 (es) 2004-09-16
AU761994C (en) 2004-01-08
HUP0100850A3 (en) 2002-12-28
KR20010033397A (ko) 2001-04-25
CA2315685A1 (en) 1999-07-01
KR100597331B1 (ko) 2006-07-10
PL192423B1 (pl) 2006-10-31
SK285662B6 (sk) 2007-05-03
AU761994B2 (en) 2003-06-12
PE20000012A1 (es) 2000-01-18
BR9813728A (pt) 2000-10-10
JP2001526227A (ja) 2001-12-18
AU1814399A (en) 1999-07-12
NO20003235D0 (no) 2000-06-21
IL136460A0 (en) 2001-06-14
CN1282245A (zh) 2001-01-31
DE69821984D1 (de) 2004-04-01
NO20003235L (no) 2000-07-27
ATE260105T1 (de) 2004-03-15
HUP0100850A2 (hu) 2001-10-28
ZA9811592B (en) 1999-06-17
HK1027040A1 (en) 2001-01-05
CZ20002304A3 (cs) 2001-04-11
CA2315685C (en) 2008-02-05
MY126580A (en) 2006-10-31
PL341344A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
DK1039922T3 (da) Forbedrede interferonpolymerkonjugater
FR2763699B1 (fr) Detecteur-optoelectronique
PT1019090E (pt) Derivados polimeros de camptotecina
DK0996565T3 (da) Foldelig cykel
NO2006014I1 (no) Insulin glulisin
NO20001776L (no) Medikamenter
DK0966477T3 (da) 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater
DE69829373D1 (de) Polymerisationsverfahren
DK0905254T3 (da) Fremgangsmåde til fremstilling af en lavemolekylær
NO20000014D0 (no) Grohemmende polymerer
DE69813694D1 (de) Polymerisationsverfahren
FR2763338B1 (fr) Nouveaux composes a base de derives de polyalkyl-1-oxa- diazaspirodecane
NO20031438D0 (no) Måling-under-boring-anordninger med stötputemonterte fölere
DK1616468T3 (da) Pakkeringe
FR2768938B1 (fr) Raquette a neige
DE69839129D1 (de) Polymerisationsverfahren
ATE260105T1 (de) Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit
DE69829006D1 (de) Triphendioxazinverbindungen
FR2760375B1 (fr) Raquette a neige
DE59810608D1 (de) Stapelvorrichtung
NO993662D0 (no) Polymerer
DE69826832D1 (de) Polymerisationsverfahren
EP0949331A4 (en) Established microglial cells
DE69811185D1 (de) Ordner
DE59806657D1 (de) Wannenabtrennung